MarketsCNBC
Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
✦ Explain it to me
CNBC
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
Not cross-checked yet
Only CNBC reports this story so far. We show it as a single source until another newsroom confirms it.
The reports
- CNBC24 Oct, 20:56
Trust score: 84/100
| Publisher CNBC (reference tier) | +82 |
| Detailed summary | +2 |
| Total | 84 |
Method: reports are grouped by the words of their headline and summary; each newsroom counts once; figures are read from the reports as published. Nothing here is written by an AI.